Cannabis - Medical
•23 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (23)
| Company | Market Cap | Price |
|---|---|---|
|
TLRY
Tilray Brands, Inc.
International medical cannabis leadership, notably in Germany.
|
$1.47B |
$1.35
+4.65%
|
|
CRON
Cronos Group Inc.
Cronos operates medical cannabis products through the PEACE NATURALS brand in Israel and other medical markets.
|
$967.40M |
$2.52
+3.07%
|
|
SNDL
SNDL Inc.
Potential medical cannabis activities exist within the company's broader cannabis platform via acquisitions and expansion, warranting Cannabis - Medical tagging.
|
$568.21M |
$2.15
+1.17%
|
|
VFF
Village Farms International, Inc.
Medical cannabis exports and international medical markets are part of the company’s strategy.
|
$356.11M |
$3.17
+3.42%
|
|
ACB
Aurora Cannabis Inc.
Direct producer of medical cannabis products sold internationally, anchored by Global Medical Cannabis revenue and high regulatory standards.
|
$271.65M |
$4.95
+2.91%
|
|
HITI
High Tide Inc.
Strategic expansion into Germany's medical cannabis market via Remexian Pharma.
|
$250.19M |
$3.12
+1.96%
|
|
CGC
Canopy Growth Corporation
Cannabis - Medical is a significant revenue segment with Canadian medical cannabis sales contributing to growth.
|
$229.64M |
$1.25
+2.05%
|
|
OGI
Organigram Global Inc.
Medical cannabis products and international medical markets.
|
$168.16M |
$1.61
+1.57%
|
|
MAPS
WM Technology, Inc.
MAPS engages with cannabis medical market activities as part of its ecosystem.
|
$162.09M |
$1.04
+1.96%
|
|
BLMH
Blum Holdings, Inc.
BLMH provides medical cannabis products alongside adult-use cannabis offerings.
|
$150.64M |
$0.65
|
|
AAWH
Ascend Wellness Holdings, Inc.
Company participates in regulated medical cannabis markets, indicating medical cannabis product offerings.
|
$150.31M |
$0.74
|
|
ANEB
Anebulo Pharmaceuticals, Inc.
Company focuses on cannabis-induced toxicity treatment, a cannabis medical indication, fitting Cannabis - Medical.
|
$108.46M |
$2.58
-2.08%
|
|
CRDL
Cardiol Therapeutics Inc.
Cannabis-based medical therapies fall under Cannabis - Medical investable theme.
|
$79.32M |
$1.12
+2.27%
|
|
PLNH
Planet 13 Holdings Inc.
Company operates medical cannabis cultivation/processing (VidaCann) and Florida MMTC assets, selling medical cannabis products.
|
$67.68M |
$0.20
|
|
INCR
InterCure Ltd.
Directly produces pharmaceutical-grade medical cannabis products and sells through regulated medical channels (GMP-certified).
|
$63.80M |
$1.40
|
|
RFL
Rafael Holdings, Inc.
Day Three Labs cannabis technology segment aligns with Cannabis - Medical.
|
$47.72M |
$1.35
+0.37%
|
|
MRMD
MariMed Inc.
Production and distribution of medical cannabis products across states where applicable.
|
$39.37M |
$0.12
|
|
IGC
IGC Pharma, Inc.
Medical cannabis/cannabinoid-based therapeutic applications in neurology and CNS disorders.
|
$33.16M |
$0.40
-0.60%
|
|
IXHL
Incannex Healthcare Limited
Cannabis - Medical captures the cannabidiol-containing component in IHL-675A.
|
$11.10M |
$0.38
-6.17%
|
|
BUDZ
WEED, Inc.
Targeting medical cannabis products and therapeutics derived from cannabis, supported by genomic research.
|
$5.44M |
$0.04
|
|
IMCC
IM Cannabis Corp.
Company focuses on breeding, cultivating, and supplying medical cannabis products, with Germany as the growth engine, aligning with Cannabis - Medical as a core segment.
|
$3.21M |
$1.45
-1.36%
|
|
CBDY
Target Group Inc.
Cannabis for medical market; licenses for cultivation, processing, and sales.
|
$1.73M |
$0.00
|
|
AKAN
Akanda Corp.
Akanda is developing a Canadian THC cannabis cultivation facility, touching regulated medical cannabis operations.
|
$668392 |
$1.59
-0.93%
|
Loading company comparison...
Loading industry trends...
Loading research report...
